Background illustration for clinical trials search

Paid Clinical Trials Baltimore

Discover 2,405 paid clinical trials in Baltimore, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,405

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

for

Urinary Urge Incontinence, Stress Urinary Incontinence,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18 - 70+

Code: NCT06161506

Phase 2, Recruiting

Genetics of Inherited Eye Disease

for

Genetic Eye Disease

Location: Bethesda MD

Sponsor: National Eye Institute (NEI)

Sex: All

Age: 1 - 70+

Code: NCT02471287

Recruiting

Data Collection of Standard Care of Patients in the EMG Section

for

Neuropathy, Muscle Disorders, Dysautonomia

Location: Bethesda MD

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 70+

Code: NCT05041387

Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for

Chronic Lymphocytic Leukemia (CLL),

Location: Bethesda MD, Nashville TN, Chicago IL, Houston TX,

Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase 1, Recruiting

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

for

Prostate Cancer

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18+

Code: NCT04692675

Recruiting

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

for

Severe Aplastic Anemia, Hypo-Plastic MDS,

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 4 - 70+

Code: NCT03173937

Phase 1, Phase 2, Recruiting

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

for

Crohn's Disease

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 65

Code: NCT03167437

Phase 1, Phase 2, Recruiting

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

for

Adrenal Gland Neoplasm, Hypertension, Bone Diseases, Metabolic,

Location: Bethesda MD

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 7 - 70

Code: NCT03374215

Recruiting

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

for

Small Cell Carcinoma of the Bladder,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06161532

Phase 2, Recruiting

Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy

for

Lipodystrophy

Location: Bethesda MD

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 0 - 70+

Code: NCT05419037

Recruiting

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

for

Neurofibromatosis Type 1

Location: Bethesda MD, Washington D.C. DC

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 70+

Code: NCT06507748

Recruiting

Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer

for

Kidney Neoplasms, Kidney Cancer, Pneumothorax,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2+

Code: NCT00033137

Recruiting

Role of Genetic Factors in the Development of Lung Disease

for

Cystic Fibrosis, Pulmonary Fibrosis, Tuberous Sclerosis, Asthma,

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 2 - 70+

Code: NCT00001532

Recruiting

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

for

Healthy Volunteers, Alcohol Use Disorder (AUD)

Location: Bethesda MD

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Sex: All

Age: 18 - 70+

Code: NCT06484075

Phase 1, Phase 2, Recruiting

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

for

Lymphoma, Primary Effusion

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05907759

Phase 2, Recruiting

Study of Skin Tumors in Tuberous Sclerosis

for

Tuberous Sclerosis

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT00001975

Recruiting

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

for

Sickle Cell Disease

Location: Bethesda MD, Richmond VA, The Bronx NY, Columbus OH,

Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT07224360

Phase 2, Recruiting

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

for

Mitochondrial Disease

Location: Bethesda MD

Sponsor: National Human Genome Research Institute (NHGRI)

Sex: All

Age: 0 - 70+

Code: NCT04419870

Recruiting

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

for

Hematologic Neoplasms

Location: Bethesda MD, Philadelphia PA

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 70+

Code: NCT04959175

Phase 1, Phase 2, Recruiting

Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers

for

Advanced Malignant Solid Neoplasm,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05691517

Phase 1, Recruiting

Paid Clinical Trials Baltimore

Filter results

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

Genetics of Inherited Eye Disease

Data Collection of Standard Care of Patients in the EMG Section

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

Interested in new trials?

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer

Role of Genetic Factors in the Development of Lung Disease

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Study of Skin Tumors in Tuberous Sclerosis

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers